GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Price-to-Free-Cash-Flow

Access Bio (XKRX:950130) Price-to-Free-Cash-Flow : N/A (As of Sep. 22, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Access Bio Price-to-Free-Cash-Flow?

As of today (2024-09-22), Access Bio's share price is ₩6340.00. Access Bio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-2,647.28. Hence, Access Bio's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Access Bio's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 12 years, Access Bio's highest Price-to-Free-Cash-Flow Ratio was 169.49. The lowest was 0.72. And the median was 17.79.

XKRX:950130's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.165
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Access Bio's Free Cash Flow per Share for the three months ended in Jun. 2024 was ₩-299.63. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₩-2,647.28.

During the past 12 years, Access Bio's highest 3-Year average Free Cash Flow per Share Growth Rate was 29.50% per year. The lowest was -71.20% per year. And the median was -38.70% per year.


Access Bio Price-to-Free-Cash-Flow Historical Data

The historical data trend for Access Bio's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Price-to-Free-Cash-Flow Chart

Access Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 30.63 4.58 1.31 -

Access Bio Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Access Bio's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Access Bio's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Access Bio's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Access Bio's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Access Bio's Price-to-Free-Cash-Flow falls into.



Access Bio Price-to-Free-Cash-Flow Calculation

Access Bio's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=6340.00/-2647.278
=N/A

Access Bio's Share Price of today is ₩6340.00.
Access Bio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,647.28.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Access Bio  (XKRX:950130) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Access Bio Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Access Bio's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Access Bio Business Description

Traded in Other Exchanges
N/A
Address
65 Clyde Road, Suite A, Somerset, NJ, USA, 08873
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio Headlines

No Headlines